|Market Size in 2021
|Market Forecast in 2028
|Growth Rate (in %)
|USD 570.1 million
|USD 818.2 million
|CAGR at 4.8%
Microcrystalline Cellulose Market
Microcrystalline cellulose is massively used as an excipient in the pharmaceutical sector owing to its superior compressibility properties. It is majorly utilized in the form of solid-like tablets. It functions as direct compression excipients which work like anti-adherent, filler, absorbent, tablet disintegrant, and dry binder.
The global microcrystalline cellulose market is likely to grow from $570.1 million in 2021 to $818.2 million by the end of 2028. It is likely to exhibit exponential growth with a healthy CAGR of 4.8% during the forecast period.
Some of the significant players in the global microcrystalline cellulose market include MingTai Chemical Co. Ltd, Sigachi Industries Pvt. Ltd, JRS PHARMA GmbH & Co. KG, Accent Microcell Pvt. Ltd, DFE Pharma GmbH & Co.KG, Roquette, Asahi Kasei Chemicals Corporation, FMC Corporation, Rayonier Advanced Material, and DowDuPont.
Asia Pacific accounts for the largest share in the global microcrystalline cellulose market due to the fast proliferating end-user sector in the region. Furthermore, the constantly growing disposable income of the people in the region will further complement the growth of the market.